Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02305342|
Recruitment Status : Completed
First Posted : December 2, 2014
Last Update Posted : March 6, 2015
|Condition or disease|
|Urinary Tract Infections (UTIs)|
Mid stream , clean catch urine specimens of patients with uncomplicated community acquired UTI sent to microbiology labs by treating consultants from filter clinics for evaluation of pathogens will be utilized for sensitivity analysis.
Only the first positive urine culture obtained per sample will be included in the analysis to eliminate any possibility of recurrence and nosocomial infection. The polymicrobial cultures and cultures with multidrug-resistant uropathogens will not be included in the analysis. Cultures with common contaminants, including coagulase-negative staphylococci and hemolytic streptococci, and cultures with Candida growth will be excluded. .
Data points to be collected will be date of collection, computer generated Lab #, age, gender,list of cultured organisms, sensitivity of organisms with antibiotics.
|Study Type :||Observational|
|Actual Enrollment :||350 participants|
|Official Title:||Antibiotic Susceptibility of Bacterial Uro-Pathogens In Patients Attending Family Physicians" (In Vitro Study)|
|Study Start Date :||November 2014|
|Actual Primary Completion Date :||February 2015|
|Actual Study Completion Date :||February 2015|
Urinary Tract Infections (UTIs)
- Sensitivity of Uropathogens [ Time Frame: 3 months ]Sensitivity of identified organisms shall be noted by the zone size in millimeters of the cultured organisms. "Sensitive", "Intermediate" and "Resistant" labels shall be used as per Clinical Laboratory Standard Institute (CLSI) guidelines.
- Common UTI pathogens [ Time Frame: 3 months ]To enlist the number and names of identified uropathogens from urine cultures.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02305342
|Research facility ID ORG-001126|
|Karachi, Pakistan, 75190|
|Study Director:||Raeefuddin Ahmed, MBBS, FCPS||Abbott|